DOJ, EUSA Pharma settle false claims action
Compliance Monitor, March 28, 2012
EUSA Pharma, a radiopharmceutical company based in Langhorne, Pa., has agreed to pay $180,000 to settle false claims allegations stemming from its suspected practice of encouraging providers to submit inflated claims to Medicare, according to a March 23 Department of Justice press release.
The Society of Nuclear Medicine informed the company that only one claim may be submitted for scans using ProstaScint, a EUSA Pharma product, according to court documents. However, EUSA Pharma still encouraged providers to submit multiple claims for images.
Read more on the U.S. Department of Justice website.
Related Products
-
Strategies for Health Care Compliance
News and real-life examples to increase the effectiveness of your compliance program. Strategies for Health Care Compliance...
-
Medicare Insider
Each issue of Medicare Weekly Update includes the latest CMS proposed and final rules, CMS manual revisions, and...
-
Strategies for Health Care Compliance-Electronic_1year
News and real-life examples to increase the effectiveness of your compliance program. Strategies for Health Care Compliance...
-
Strategies for Health Care Compliance
News and real-life examples to increase the effectiveness of your compliance program. Strategies for Health Care Compliance...
Most Popular
- Articles
-
- Don't forget the three checks in medication administration
- Know guidelines and subtle differences in code descriptions for laceration repairs
- Practice the six rights of medication administration
- Nursing responsibilities for managing pain
- Note similarities and differences between HCPCS, CPT® codes
- CMS seeks comment on quality measures
- Steps for maintaining patient privacy
- Complications from immobility by body system
- The five key elements of a good orientation program
- Prevent dehydration with nursing interventions
- E-mailed
- Searched